Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
NATCO Pharma Limited is a science-driven global pharmaceutical company focused on complex generics and niche molecules, with a revenue of ₹47,840 million in FY25 and over 5,000 employees worldwide. It offers a broad portfolio of pharmaceutical formulations for domestic and international markets, including oncology, gastroenterology/hepatology, neurology, cardiology/diabetology, and infectious diseases/HIV, along with an extensive active pharmaceutical ingredients portfolio, exporting to more than 50 countries from 9 manufacturing facilities and 2 R&D centers. NATCO also operates Crop Health Sciences and Agro Formulations, and emphasizes sustainability and ongoing R&D to make specialty medicines accessible.
Parse Score